Closed · CDC-RFA-IP10-0070201SUPP12 · CFDA 93.185 · Discretionary

Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season

Federal grant opportunity posted by Centers for Disease Control and Prevention, cataloged on Grants.gov.

Varies
Award range
Closed
Status
August 10, 2012
Close date
-
Expected awards

The verdict

Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season is a closed discretionary listing from Centers for Disease Control and Prevention that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 1,727 other opportunities from Centers for Disease Control and Prevention.

Varies
award range
Closed
application status
93.185
CFDA program
1,727
other opportunities from Centers for Disease Control and Prevention

Archived opportunity record

Effectiveness of Empiric Antiviral Treatment… is closed (last close August 10, 2012). Check the agency catalog for replacement NOFOs. Centers for Disease Control and Prevention still indexes 1,727 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed August 10, 2012

Posted Jul 30 Closes Aug 10

Est. Total Funding

$846,000

Instrument

Cooperative Agreement

Description

The purpose of the program is to continue the objectives of FOA IP10-007 to determine the effectiveness of empiric influenza antiviral therapy, in addition to empiric antibiotic therapy, for hospitalized CAP patients, and other patients with lower respiratory tract illness, during the periods when influenza viruses are circulating in the community. This program addresses the “Healthy People 2020” focus area(s) of Immunization and Infectious Diseases.

Catch-all / unrestricted eligibility mark · CDC-RFA-IP10-0070201SUPP12

Grants.gov marks Effectiveness of Empiric Antiviral Treatment… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Centers for Disease Control and Prevention book (1,452 peers, 84% of 1,728).

Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

CDC Procurement and Grants Office TIMS Phone 770-488-2700

What to do next

Effectiveness of Empiric Antiviral Treatment… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.185 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Centers for Disease Control and Prevention lists 1,727 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants